Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: Analytical study

Lancet

Volumn 363, Issue 9427, 2004, Pages 2128-2135

  Arlt, Wiebke ^a   Walker, Elizabeth A ^a   Draper, Nicole ^a   Ivison, Hannah E ^a   Ride, Jon P ^b   Hammer, Fabian ^a   Chalder, Susan M ^a   Borucka Mankiewicz, Maria ^d   Hauffa, Berthold P ^c   Malunowicz, Ewa M ^d   Stewart, Paul M ^a   Shackleton, Cedric H L ^e  

^a Medical School   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^e CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYTOCHROME P450C17; MUTANT PROTEIN; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID 21 MONOOXYGENASE;

ANDROGEN SYNTHESIS; ARTICLE; CASE REPORT; CONGENITAL ADRENAL HYPERPLASIA; ELECTRON TRANSPORT; ENZYME ACTIVITY; FAMILY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; WILD TYPE;

EID: 3042613405     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16503-3     Document Type: Article

References (33)

1. Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases: a new variant of congenital adrenal hyperplasia. N Engl J Med. 313:1985;1182-1191
2. Reardon W, Smith A, Honour JW, et al. Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? J Med Genet. 37:2000;26-32
3. Shackleton C, Malunowicz E. Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome. Steroids. 68:2003;707-717
4. Adachi M, Tachibana K, Asakura Y, Suwa S, Nishimura G. A male patient presenting with major clinical symptoms of glucocorticoid deficiency and skeletal dysplasia, showing a steroid pattern compatible with 17α-hydroxylase/17, 20-lyase deficiency, but without obvious CYP17 gene mutations. Endocr J. 46:1999;285-292
5. Miller WL. Congenital adrenal hyperplasia. N Engl J Med. 314:1986;1321-1322
6. Shackleton C, Marcos J, Malunowicz EM, et al. Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis. Am J Med Genet (published online April 5, 2004). DOI: 10.1002/ajmg.a.30104.
7. Shackleton CH. Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol. 45:1993;127-140
8. Caulfield MP, Lynn T, Gottschalk ME, et al. The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J Clin Endocrinol Metab. 87:2002;3682-3690
9. Asanuma A, Ohura T, Ogawa E, et al. Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency. J Hum Genet. 44:1999;312-317
10. Lin D, Harikrishna JA, Moore CC, Jones KL, Miller WL. Missense mutation serine106→proline causes 17α-hydroxylase deficiency. J Biol Chem. 266:1991;15992-15998
11. Witchel SS, Lee PA, Trucco M. Who is a carrier? Detection of unsuspected mutations in 21-hydroxylase deficiency. Am J Med Genet. 61:1996;2-9
12. Auchus RJ, Lee TC, Miller WL. Cytochrome b5 augments the 17, 20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem. 273:1998;3158-3165
13. Walker EA, Clark AM, Hewison M, Ride JP, Stewart PM. Functional expression, characterization, and purification of the catalytic domain of human 11β-hydroxysteroid dehydrogenase type 1. J Biol Chem. 276:2001;21343-21350
14. Smith GC, Tew DG, Wolf CR. Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. Proc Natl Acad Sci USA. 91:1994;8710-8714
15. Shen AL, Porter TD, Wilson TE, Kasper CB. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. J Biol Chem. 264:1989;7584-7589
16. Lamb DC, Warrilow AG, Venkateswarlu K, Kelly DE, Kelly SL. Activities and kinetic mechanisms of native and soluble NADPH-cytochrome P450 reductase. Biochem Biophys Res Commun. 286:2001;48-54
17. Wang M, Roberts DL, Paschke R, Shea TM, Masters BS, Kim JJ. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc Natl Acad Sci USA. 94:1997;8411-8416
18. Shen AL, Kasper CB. Differential contributions of NADPH-cytochrome P450 oxidoreductase FAD binding site residues to flavin binding and catalysis. J Biol Chem. 275:2000;41087-41091
19. Wilson JD, Auchus RJ, Leihy MW, et al. 5α-androstane-3α, 17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α, 17α-diol-20-one as a key intermediate. Endocrinology. 144:2003;575-580
20. Gupta MK, Guryev OL, Auchus RJ. 5alpha-reduced C21 steroids are substrates for human cytochrome P450c17. Arch Biochem Biophys. 418:2003;151-160
21. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab. 78:1994;1287-1292
22. Carani C, Qin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med. 337:1997;91-95
23. Herrmann BL, Saller B, Janssen OE, et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab. 87:2002;5476-5484
24. Roth C, Hinney B, Peter M, Steinberger D, Lakomek M. Features of Antley-Bixler syndrome in an infant born to a mother with pregnancy luteoma. Eur J Pediatr. 159:2000;189-192
25. Kelley RI, Kratz LE, Glaser RL, Netzloff ML, Wolf LM, Jabs EW. Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. Am J Med Genet. 110:2002;95-102
26. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet. 8:1994;98-103
27. Chun K, Siegel-Bartelt J, Chitayat D, Phillips J, Ray PN. FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet. 77:1998;219-224
28. Tsai FJ, Wu JY, Yang CF, Tsai CH. Further evidence that fibroblast growth factor receptor 2 mutations cause Antley-Bixler syndrome. Acta Paediatr. 90:2001;595-597
29. Fluck CE, Tajima T, Pandey AV, et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet. 36:2004;228-230
30. Shen AL, O'Leary KA, Kasper CB. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J Biol Chem. 277:2002;6536-6541
31. Otto DM, Henderson CJ, Carrie D, et al. Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis. Mol Cell Biol. 23:2003;6103-6116
32. Geller DH, Auchus RJ, Mendonca BB, Miller WL. The genetic and functional basis of isolated 17, 20-lyase deficiency. Nat Genet. 17:1997;201-205
33. Draper N, Walker EA, Bujalska IJ, et al. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet. 34:2003;434-439